MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia. - Wikidata - wikimedia - TriplyDB

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q33333245

about

Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population.Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.Single-nucleotide polymorphisms in the p53 signaling pathway.MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group.Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma Molecular pathways: regulation and therapeutic implications of multidrug resistance A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients.Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene.The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models.Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.miR deregulation in CLL.Functional assessment of p53 in chronic lymphocytic leukemia.Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma.Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: the association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib.MDM2 SNP309 and p53 Arg72Pro in cutaneous melanoma: association between SNP309 GG genotype and tumor Breslow thickness.A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.Use of genome-wide high-throughput technologies in biomarker development A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome

P2860

Q27853395-A742D1C8-060E-4FFA-8489-EE029BA8B74E Q28536735-23DDDB2B-4280-4873-98A3-056767EED676 Q30840070-C3FA59E6-8EA5-4B0C-B4B0-ED2624D4CFD6 Q33557871-F09C5849-339C-4A90-B3F7-9BE4C8583869 Q33627208-5A2E5FD0-B3C3-40A5-953D-18F8A45C315D Q33800384-B49E5F77-E753-4E7B-8620-6454BA99993B Q34043467-632BCCE6-5726-4D33-912C-439954D9ED59 Q34255215-133EC0DC-2BE1-4429-B408-8ADB944C4B37 Q34255292-7F9CD687-A4C2-418E-80A1-F442C5C0FDD4 Q34626391-E7AF493C-B629-47B0-AF38-E373E2CCDCD2 Q35169579-30A8926B-88C5-452E-BC63-EDCA96DD3A95 Q35496723-66A47067-5865-42C7-91BC-D432C81533CA Q35650512-CF58F1BF-D050-449F-8EA4-11B4CBCA463C Q37195909-E4465594-5AAA-4C08-9741-2BC9EE01FB9D Q37238851-86483B9D-46C1-44CD-9D42-0E76BB869C47 Q37287418-15055A64-B4EA-4975-BEB5-F80154D07D61 Q37588785-A5B80E79-3E3C-4791-BE4B-56C2EC69EBD3 Q37603583-BB2A06C3-9E40-4996-904E-34414E6492B0 Q37978967-9CE72920-5C7F-485A-A467-45CA39B27AEE Q38135352-F338328F-C5BB-48D3-AF1E-BA38833AE122 Q40298340-9BA22A0E-23D5-4DE0-95FB-773CA2A6ADA2 Q43199551-89FD24E2-09DC-45FE-B840-A40BB84BB956 Q44416876-0457272E-0867-4E8C-9F52-857EAB7C4C52 Q44745420-2926E874-23CB-4655-ACAA-AE14692EB81E Q47799677-FF918510-FD06-45E6-8432-F9B66B3536D8 Q50864357-FB8C0A25-2CFB-4678-BEF9-A3D590DBA219 Q51560962-0C1BB7CE-E5AE-46F8-BDAD-11B665D56101 Q53288178-BCA0F0B4-DCE8-4E9E-B3BE-78DDE2ABC3A5 Q57556407-4D47427E-60A3-4223-8333-21EEF630EDAE Q58000942-7FC84939-9C62-4A64-BC88-98DFA40BBC8D

P2860

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q33333245

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@ast

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@en

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@nl

type

label

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@ast

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@en

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@nl

prefLabel

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@ast

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@en

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@nl

P1433

Q33333245-10782937-7EE0-4678-81D0-E87BA299E033

P1476

Q33333245-4163D247-AE36-479F-BA0E-70C17563364A

P2093

Q33333245-0B28A48A-4C2A-4C43-AB87-F74F2BB9574D

Q33333245-31749424-82A4-4AAA-8E31-1FCBED3980DE

Q33333245-3BA82A4E-9475-46C8-8085-761AAC67E8B1

Q33333245-3E709D35-60D3-400F-B0DC-57DAF13985D4

Q33333245-48D6E742-38CE-489D-AC4F-E1F006EAEA15

Q33333245-8F616C60-EAC7-4D1C-8CBA-5DE0402C12DC

Q33333245-B7C82D45-0C4B-4FBA-A5AF-7A2B3548C97C

Q33333245-F389A6CA-3220-463B-9FE7-8A8DAB739EA8

Q33333245-F7D8A28B-B66D-4CE6-8864-168C74E42B76

P304

Q33333245-3397E2E3-2A9C-45B3-83BF-B6F9C80D1254

P31

Q33333245-642DC9DF-9FCB-4A0E-B883-20DD513E3A83

P356

Q33333245-A1B1F4D7-2918-4429-A81D-CAC305542168

P407

Q33333245-535ADA62-65A3-4FE6-AFCC-7657042C60EF

P433

Q33333245-EE1E8D8F-8827-4E7B-8714-E1E4377BFBAD

P478

Q33333245-9E67AE4B-137D-49B0-AC01-951C45B6C545

P577

Q33333245-75062602-184E-4CF2-B91B-656AB9840E78

P698

Q33333245-24417612-B5F1-4548-ADD6-B301B5664850

P921

Q33333245-4B204055-B29D-4E21-88C9-9352941D6F4C

Q33333245-55393A10-B9BF-46EF-BF52-D6CE894D3F52

P356

JCO.2007.11.5212

P1433

Journal of Clinical Oncology

P1476

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

@en

P2093

Alexander Gaiger

http://www.w3.org/2001/XMLSchema#string

Inge Tinhofer

http://www.w3.org/2001/XMLSchema#string

Irina Gryshchenko

http://www.w3.org/2001/XMLSchema#string

Karin Eigenberger

http://www.w3.org/2001/XMLSchema#string

Markus Stoecher

http://www.w3.org/2001/XMLSchema#string

Michael Steurer

http://www.w3.org/2001/XMLSchema#string

Peter T Daniel

http://www.w3.org/2001/XMLSchema#string

Richard Greil

http://www.w3.org/2001/XMLSchema#string

Sebastian Hofbauer

http://www.w3.org/2001/XMLSchema#string

P304

2252-2257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2007.11.5212

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18467716

http://www.w3.org/2001/XMLSchema#string

P921